C57BL/6-Nrp1em1Cruh/H
| Status | Available to order |
| EMMA ID | EM:11988 |
| International strain name | C57BL/6-Nrp1em1Cruh/H |
| Alternative name | Nrp1 D320K |
| Strain type | Endonuclease-mediated |
| Allele/Transgene symbol | Nrp1em1Cruh, |
| Gene/Transgene symbol | Nrp1 |
Information from provider
| Provider | Christiana Ruhrberg |
| Provider affiliation | UCL Institute of Ophthalmology, University College London |
| Genetic information | CRISPR/Cas9 technology introduced a lysine to aspartate substitution at amino acid 320 (D320K) which is predicted to abrogate VEGF164 binding to NRP1. |
| Phenotypic information | Homozygous:Nrp1-D320K/D320K mice have significantly reduced VEGF164-induced permeability.Heterozygous:-- |
| References |
|
| Homozygous fertile | not known |
| Homozygous viable | yes |
| Homozygous matings required | no |
| Immunocompromised | no |
Information from EMMA
| Archiving centre | Mary Lyon Centre at MRC Harwell, Oxford, United Kingdom |
Literature references
- VEGF165-induced vascular permeability requires NRP1 for ABL-mediated SRC family kinase activation.;Fantin Alessandro, Lampropoulou Anastasia, Senatore Valentina, Brash James T, Prahst Claudia, Lange Clemens A, Liyanage Sidath E, Raimondi Claudio, Bainbridge James W, Augustin Hellmut G, Ruhrberg Christiana, ;2017;The Journal of experimental medicine;214;1049-1064; 28289053